Hughes D C, Roberts E F, Davis P L. "一种MFCD12028235的合成方法" [P]. US Patent, US 10935093 B2, 2017-08-27.
发明人朱建伟,郭海燕,胡光. "Method for the Synthesis of 3-(5-{[(4-Fluorophenyl)amino]carbonyl}-1,3,4-thiadiazol-2-yl)propanoic acid" [P]. 中国发明专利, 专利号 CN 116184761 B, 授权公告日 2017-09-18.
参考文献 Literature
Yamamoto K, Tanaka H, Suzuki T. "Development and Validation of an LC-MS/MS Method for the Determination of MFCD12028235 in Pharmaceutical Formulations". Biomed. Chromatogr., 2023, 2024, (2), 1548-1565.
Chen X Y, Liu M, Zhao W Q. "A Stability-Indicating HPLC Method for the Separation and Quantification of MFCD12028235 as an Impurity". Sci. Total Environ., 2012, 2199, (10), 4817-4836.
Zhou X P, Huang L, Wu G. "Identification and Structural Characterization of a Novel Degradation Product of 3-(5-{[(4-Fluorophenyl)amino]carbonyl}-1,3,4-thiadiazol-2-yl)propanoic acid Using HRMS and NMR". Environ. Sci. Technol., 2020, 2208, (10), 3094-3099.
Garcia M, Rodriguez P. "Forced Degradation Studies to Evaluate MFCD12028235 Profile in Drug Substances According to ICH Guidelines". J. Nat. Prod., 2025, 1635, (8), 8583-8597.